2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jain S et al. | Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles. | 2018 | AAPS PharmSciTech | pmid:28785860 |
| Souza C et al. | Effect of Liquid Crystalline Systems Containing Antimicrobial Compounds on Infectious Skin Bacteria. | 2017 | AAPS PharmSciTech | pmid:28028794 |
| Nielsen LH et al. | Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. | 2017 | Eur J Pharm Biopharm | pmid:27993733 |
| Jang Y et al. | Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase. | 2017 | Acta Pharmacol. Sin. | pmid:27867185 |
| Mishraki-Berkowitz T et al. | Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase. | 2017 | J Colloid Interface Sci | pmid:27701016 |
| Shi X et al. | Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo. | 2017 | Pharm Dev Technol | pmid:26670780 |
| Muheem A et al. | A Combinatorial Statistical Design Approach to Optimize the Nanostructured Cubosomal Carrier System for Oral Delivery of Ubidecarenone for Management of Doxorubicin-Induced Cardiotoxicity: In Vitro-In Vivo Investigations. | 2017 | J Pharm Sci | pmid:28552692 |
| Levin A et al. | Lipid Phase Control and Secondary Structure of Viral Fusion Peptides Anchored in Monoolein Membranes. | 2017 | J Phys Chem B | pmid:28829131 |
| Gabr MM et al. | Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study. | 2017 | J Pharm Sci | pmid:28479357 |
| Szlezak M et al. | Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release. | 2017 | ACS Appl Mater Interfaces | pmid:28029248 |